BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6381284)

  • 1. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS; Aterman K
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
    Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
    Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
    Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
    J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT; Tuttle SE; Strobel SL; Gandhi L
    J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
    Epstein JI; Woodruff JM
    Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
    Steffens J; Friedmann W; Lobeck H
    Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
    Warhol MJ; Longtine JA
    J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
    Fan K
    J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
    Sauvageot J; Epstein JI
    Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
    Mathieu MC; Caillaud JM
    Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
    Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
    Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
    Svanholm H
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma].
    Yamaguchi K; Sumiya H; Fuse H; Ito H; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):786-90. PubMed ID: 2427766
    [No Abstract]   [Full Text] [Related]  

  • 18. Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
    Ro JY; el-Naggar A; Ayala AG; Mody DR; Ordóñez NG
    Am J Surg Pathol; 1988 Jun; 12(6):453-60. PubMed ID: 2454036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
    Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
    Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.